The estimated Net Worth of David Stuart Hinton is at least $777 mil dollars as of 27 February 2021. Mr. Hinton owns over 2,668 units of Covetrus stock worth over $108,413 and over the last 5 years he sold CVET stock worth over $668,757. In addition, he makes $0 as Executive Vice President y President - APAC and Emerging Marke at Covetrus.
David has made over 5 trades of the Covetrus stock since 2020, according to the Form 4 filled with the SEC. Most recently he exercised 2,668 units of CVET stock worth $56,001 on 27 February 2021.
The largest trade he's ever made was exercising 26,763 units of Covetrus stock on 14 January 2021 worth over $561,755. On average, David trades about 5,051 units every 37 days since 2020. As of 27 February 2021 he still owns at least 5,165 units of Covetrus stock.
You can see the complete history of Mr. Hinton stock trades at the bottom of the page.
David Hinton serves as Executive Vice President, President - APAC and Emerging Marke of the Company. From February 2019 until such appointment, Mr. Hinton served as Senior Vice President and President APAC and Emerging Markets. From April 2016 until February 2019, Mr. Hinton served as Vice President and Managing Director—ANZ, and from January 2011 to April 2016 as Vice President and Managing Director—UK, Ireland and France of Henry Schein Animal Health. Mr. Hinton holds a Post Graduate Diploma in Management Studies, and a Diploma in Marketing from the University of the West of England.
David Hinton is 59, he's been the Executive Vice President y President - APAC and Emerging Marke of Covetrus since 2020. There are 7 older and 19 younger executives at Covetrus. The oldest executive at Covetrus, Inc. is Philip Laskawy, 78, who is the Independent Chairman of the Board.
David's mailing address filed with the SEC is 7, Custom House Street, India Street, Portland, Cumberland County, Maine, 04101, United States.
Over the last 5 years, insiders at Covetrus have traded over $10,243,394 worth of Covetrus stock and bought 11,744 units worth $216,180 . The most active insiders traders include Steven Paladino, Benjamin Wolin y Philip A Laskawy. On average, Covetrus executives and independent directors trade stock every 10 days with the average trade being worth of $268,798. The most recent stock trade was executed by Rebecca Ann Kidd on 1 October 2022, trading 1,232 units of CVET stock currently worth $25,860.
Covetrus, Inc., together with its subsidiaries, operates as an animal-health technology and services company. It engages in the sale of animal-health consumable products, including proprietary and Covetrus branded products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, parasiticides, and vitamins and supplements to wholesale and retail customers. The company also offers value-added solutions that include, inventory management and e-commerce, as well as continuing education services for practitioners. In addition, it provides practice management software systems for veterinary practitioners and animal-health clinics, client communication services, reminders, data backup services, and hardware sales and support services. Further, the company engages in the distribution of finished goods pharmacy and specialty pharmaceutical compounding products, as well as shipping, manufacturer incentives, service fees, and data integration and support services. It serves animal-health and veterinary practices, and clinics in the companion-animal and equine markets primarily in North America, Europe, and the Asia Pacific. The company was formerly known as HS Spinco, Inc. Covetrus, Inc. was incorporated in 2018 and is headquartered in Portland, Maine.
Covetrus executives and other stock owners filed with the SEC include: